MANUFACTURERS LIFE INSURANCE COMPANY, THE - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 184 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$17,551,977
+315.2%
665,604
+170.8%
0.01%
+400.0%
Q2 2023$4,227,605
+475.5%
245,791
+454.7%
0.00%
Q1 2023$734,660
+119.6%
44,310
+0.9%
0.00%
Q4 2022$334,533
-21.7%
43,902
+2.1%
0.00%
Q3 2022$427,470
+7.5%
43,005
-1.8%
0.00%
Q2 2022$397,686
-13.3%
43,798
-3.1%
0.00%
Q1 2022$458,618
-49.7%
45,184
-17.3%
0.00%
-100.0%
Q4 2021$912,000
-65.4%
54,664
-2.8%
0.00%
-50.0%
Q3 2021$2,636,000
-29.6%
56,236
-8.5%
0.00%
-33.3%
Q2 2021$3,745,000
+10.8%
61,436
+12.0%
0.00%0.0%
Q1 2021$3,380,000
+6.6%
54,873
+23.0%
0.00%0.0%
Q4 2020$3,172,000
+95.7%
44,603
+3.2%
0.00%
+50.0%
Q3 2020$1,621,000
+12.1%
43,213
-2.6%
0.00%
+100.0%
Q2 2020$1,446,000
+4.8%
44,367
-6.8%
0.00%
-50.0%
Q1 2020$1,380,000
+146.0%
47,602
+197.4%
0.00%
+100.0%
Q4 2019$561,000
+75.3%
16,008
+0.7%
0.00%
Q3 2019$320,00015,8940.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,835,722$103,449,00044.18%
Kohlberg Kravis Roberts & Co. L.P. 36,900,661$995,211,00012.26%
SC US (TTGP), LTD. 2,544,738$68,632,0004.69%
Cormorant Asset Management, LP 2,780,885$75,000,0004.31%
Perceptive Advisors 6,706,268$180,868,0004.15%
VIKING GLOBAL INVESTORS LP 26,620,991$717,968,0003.22%
Hillhouse Capital Management 2,035,790$54,905,0001.75%
Alpine Group USVI, LLC 20,000$539,0001.70%
HHLR ADVISORS, LTD. 2,352,900$63,458,0001.42%
SCGE MANAGEMENT, L.P. 588,235$15,865,0000.79%
View complete list of BRIDGEBIO PHARMA INC shareholders